PATENT CLAIM ANALYSIS

Application Number: 16069201
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["544", "272000"]

Abstract:
This disclosure features dinucleotide compounds that modulate Stimulator of Interferon Genes (STING) activity, for use for example in the treatment of cancer. This disclosure also features compositions as well as other methods of using and making the same. A and B are each independently selected from the group consisting of Formulae (i), (ii), (iii), and (iv):

Claim (Index 151):
The compound according to  claim 149  wherein the compound has the following formula:

Metadata:
- Claim Count in Document: 51.0
- Percentile: 95.0
- Lexical Diversity: 1.4898
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12813148', '14403763', '14358606', '14324560', '15040475']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7528281996522764
- 35 USC 102 Novelty (BERT): 0.5238816696742972
- Combined Prediction Score: 0.7299335466544785
- Mean Citation Score: 274.031962
- Max Citation Score: 275.4618
- Similarity Product: 154.68223018620012

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test